Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seungwon Kim

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
American Journal of Otolaryngology|August 13, 2024
Association of prealbumin with complications after total laryngectomy with free flap reconstructionAnthony Tang, Sophia Dang, Isabella Lao, et al.
Molecular Cancer Therapeutics|November 24, 2006
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse modelMaher N Younes, Young Wook Park, Yasemin Dakak Yazici, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinomaZhuoying Wang, Geetika Chakravarty, Seungwon Kim, et al.
Oral Oncology|August 18, 2016
Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinomaWilliam G Albergotti, Kara S Davis, Shira Abberbock, et al.
Molecular Cancer Therapeutics|August 12, 2005
Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancerMaher N Younes, Seungwon Kim, Orhan G Yigitbasi, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|August 23, 2024
Association of Patient and Tumor Characteristics With Outcomes in Young Head and Neck Squamous Cell Carcinoma PatientsRonan W Hsieh, William E Gooding, Marci Nilsen, et al.
Head & Neck|April 16, 2016
Oncologic outcomes of surgically treated early-stage oropharyngeal squamous cell carcinomaJason I Kass, Laureano Giraldez, William Gooding, et al.
Cancer|October 7, 2018
Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlativesJulie E Bauman, Umamaheswar Duvvuri, Sufi Thomas, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neckJohn A Vargo, Robert L Ferris, James Ohr, et al.
The Laryngoscope|January 11, 2021
PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal CancerVusala Snyder, Lindsey K Goyal, Eve M R Bowers, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
American Journal of Otolaryngology|August 13, 2024
Association of prealbumin with complications after total laryngectomy with free flap reconstructionAnthony Tang, Sophia Dang, Isabella Lao, et al.
Molecular Cancer Therapeutics|November 24, 2006
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse modelMaher N Younes, Young Wook Park, Yasemin Dakak Yazici, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinomaZhuoying Wang, Geetika Chakravarty, Seungwon Kim, et al.
Oral Oncology|August 18, 2016
Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinomaWilliam G Albergotti, Kara S Davis, Shira Abberbock, et al.
Molecular Cancer Therapeutics|August 12, 2005
Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancerMaher N Younes, Seungwon Kim, Orhan G Yigitbasi, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|August 23, 2024
Association of Patient and Tumor Characteristics With Outcomes in Young Head and Neck Squamous Cell Carcinoma PatientsRonan W Hsieh, William E Gooding, Marci Nilsen, et al.
Head & Neck|April 16, 2016
Oncologic outcomes of surgically treated early-stage oropharyngeal squamous cell carcinomaJason I Kass, Laureano Giraldez, William Gooding, et al.
Cancer|October 7, 2018
Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlativesJulie E Bauman, Umamaheswar Duvvuri, Sufi Thomas, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neckJohn A Vargo, Robert L Ferris, James Ohr, et al.
The Laryngoscope|January 11, 2021
PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal CancerVusala Snyder, Lindsey K Goyal, Eve M R Bowers, et al.
Pageof 15